Genmab — April 2020

[bibob]

Tak, DevOp. , har altid været ydmyg.

[JKY_VH]

Du er da rigtig nostalgisk i aften. Nej lad os håbe, at der ikke kommer flere biotekselskaber á la NeuroSearch:-)

[Helge_LarsenPI-redaktør]

God morgen.

[GeorgeBest]

DaraRVd https://twitter.com/phari/status/1253749884894707712?s=21

[GeorgeBest]

Endnu et GRIFFIN tweet https://twitter.com/transplant_doc/status/1253740177903824902?s=21

[peter12]

Var det ikke et krav for at komme på compendia listing ? At resultatet blev publiceret og peer reviewet ?

[peter12]

JVdW: As we released yesterday, the GRIFFIN data is very impressive and will be presented in full at the upcoming IMW meeting in Boston in September and may very rapidly be published in a peer-reviewed journal. On top of that, the D-RVD regimen may then be included in US compendia, and thus be reimbursed https://nbg1.your-objectstorage.com/proinvestor-dev/forum/ir/cms/QA-Genmab 2019-08-20.pdf

[GeorgeBest]

Ja vi mangler vel publikation i
NEJM eller Lancet?

[Bulder]

Blood skulle være godt nok https://en.wikipedia.org/wiki/Blood_(journal)

[StockBull]

Genmab tilbage i stærk stil https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/83940_5_year_chart.JPG

[GeorgeBest]

Tak Bulder, så burde den være OK

[Helge_LarsenPI-redaktør]

God morgen

[Helge_LarsenPI-redaktør]

Healthcare har genvundet hele årets tab:
https://www.proinvestor.com/investornyt/659641/stoxx-sektorer-healtcare-tilbage-ved-arsstart-banker-fortsat-i-bund

[transalp]

Go morgen..

[transalp]

Go morgen.. det var en stille søndag..

[bibob]

God morgen

[bibob]

Og endelig kom regnen.

[transalp]

Den venter jeg stadig på heroppe nord på, regen altså.. og en go gen uge,

[E_L]

Halozyme Announces Janssen Submits New Drug Application In Japan For Daratumumab Subcutaneous Formulation Utilizing Halozyme's ENHANZE Technology For Patients With Multiple Myeloma https://www.halozyme.com/investors/news-releases/news-release-details/2020/Halozyme-Announces-Janssen-Submits-New-Drug-Application-In-Japan-For-Daratumumab-Subcutaneous-Formulation-Utilizing-Halozymes-ENHANZE-Technology-For-Patients-With-Multiple-Myeloma/default.aspx

[gentogen]

ADC THERAPEUTICS FILES REGISTRATION STATEMENT FOR PROPOSED INITIAL PUBLIC OFFERING https://adctherapeutics.com/press_release/adc-therapeutics-announces-first-patient-dosed-in-phase-i-clinical-trial-of-adct-402-loncastuximab-tesirine-and-ibrutinib-in-patients-with-advanced-diffuse-large-b-cell-lymphoma-or-mantle-cell-lymp-12/